Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in Percent.
The item "Net-Buyback-Yield" stands at 1.62 percent as of 09/30/2025.
As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Net Buyback Yield" stands at 1.62 Percent. This represents a decrease of -0.03 percentage points compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 1.59 percentage points compared to the value the year prior.
The 1 year change in percentage points is 1.59.
The 3 year change in percentage points is -0.5039.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Net Buyback Yield | 905,699,262,464.00 |
![]() | Johnson & Johnson - Net Buyback Yield | 486,508,953,600.00 |
![]() | AbbVie Inc - Net Buyback Yield | 399,570,305,024.00 |
![]() | Roche Holding AG - Net Buyback Yield | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Net Buyback Yield | 280,205,508,085.11 |